Login / Signup

Interdental Papillary Reconstruction by Microtunnelling Technique Using Autologous Biomatrices-A Randomised Controlled Clinical Trial.

Sindhura GadiSangeetha SubramanianP S G PrakashDevapriya AppukuttanAbirami ThanigaimalaiMaha A BahammamKhalid J AlzahraniKhalaf F AlsharifIbrahim Faisal F HalawaniMrim M AlnfiaiThodur Madapusi BalajiShankaragouda Patil
Published in: Medicina (Kaunas, Lithuania) (2022)
Background and objectives : The study aimed to evaluate and compare the amount of papillary gain and black triangle height reduction after intervention with a microtunnelling technique with either Connective tissue graft (CTG) or Platelet-rich fibrin (PRF) as a biomatrix at 6 months using a microsurgical approach. Materials and Methods: Twenty-six patients with interdental papillary loss were included in the study. The patients were selected randomly for the study groups with thirteen patients in each group: a control group where CTG was utilised as a matrix, and a test group where PRF was utilised as a matrix, for interdental papillary reconstruction. A microtunnelling technique was performed for both the study groups under a surgical microscope. The primary parameters assessed were interdental Papillary height (PH) and Black triangle height (BTH) at baseline, with secondary parameters Visual analogue score by dentist (VAS-D) and patient (VAS-P) assessed at 6 months. Results: Both the control and test groups showed a significant reduction in BTH within their respective group at six months ( p < 0.05). The gain in papillary height significantly improved only in the CTG group at 6 months. However, significant differences could not be demonstrated for any of the variables such as BTH ( p value = 0.582) and PH ( p -value = 0.892) between the study groups at 6 months. Conclusions: IDP reconstruction utilising a microtunnelling approach with CTG or PRF was successful without any significant differences between the groups for the parameters assessed at 6 months.
Keyphrases
  • clinical trial
  • body mass index
  • end stage renal disease
  • randomized controlled trial
  • chronic kidney disease
  • stem cells
  • newly diagnosed
  • platelet rich plasma